Pharmaceuticals - Global Generic & Specialty Drugs
Strategic Profile
Lupin operates a highly diversified pharmaceutical business with a strong presence across key global markets, with operations spanning generics, complex formulations, branded products, and other high-burden specialty segments, supported by robust R&D and manufacturing capabilities. The company achieved an S&P Global ESG Score of 91, ranking as World No. 1 in sustainability in the pharmaceutical industry as of February 7, 2026.
Cyborg Score Rationale
Lupin demonstrates solid operational scale with $10.4B market cap and $2.81B trailing revenue, strong global diversification across 100+ markets, and industry-leading ESG credentials. However, the company faces headwinds with modest 8.11% five-year sales growth and relatively low 13.4% ROE, suggesting execution challenges despite market position.
Top Insights
World No. 1 in pharmaceutical industry sustainability (S&P Global ESG Score of 91 as of Feb 2026)
Diversified global footprint with presence in 100+ markets including US, India, APAC, Europe, and Latin America
Strong portfolio in high-barrier segments including complex generics, biotechnology products, and specialty medications
Recent innovation focus including licensing agreements for GLP-1 receptor agonists and proprietary long-acting injectable platforms (PrecisionSphere™)
Named Competitors
Dr. Reddy's Laboratories — Generic and specialty pharmaceuticals
Cipla — Generic formulations and branded medicines
Sun Pharmaceutical — Generic and specialty pharmaceutical products
Aurobindo Pharma — Generic and branded formulations
Recent Developments
(February 2026) Appointed Anand Kripalu as Independent Director
(February 2026) Q3 FY26 earnings announcement and investor conference
(February 2026) License and supply agreement with Spektus for DeslaFlex™ antidepressant commercialization in Canada
(Recent) FDA approval for Risperidone Long-Acting Injectable with PrecisionSphere™ platform
Open the full interactive Lupin Limited report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.